Our services have evolved over time to meet the increasing need for health economic, evidence based solutions, clinical data management, regulatory and risk management; our vast experience across a wide range of disease areas is second to none.
We provide services at every stage of the product lifecycle including:
![](images/ywfc_clip_image001.gif)
Pre-launch evaluations of disease burden and outcome evidence
![](images/ywfc_clip_image001.gif)
Registration or global trial submission
![](images/ywfc_clip_image001.gif)
Phase I-IV clinical trial management
![](images/ywfc_clip_image001.gif)
Phase II/III patient reported outcomes and economic study design, conduct, analysis, and report
![](images/ywfc_clip_image001.gif)
Development of comprehensive health economic models
![](images/ywfc_clip_image001.gif)
Input into pricing decisions and develop strategy to meet market access requirements
![](images/ywfc_clip_image001.gif)
Preparation of HTA and health outcomes value dossiers according to country requirement
![](images/ywfc_clip_image001.gif)
Development of post-launch access strategy and communication tools
![](images/ywfc_clip_image001.gif)
Develop regulatory and risk management strategic plan